That downhill slide is reflected in suggestions from disgruntled BlinkRx consumers in many other sites. On copyright, where by the assessments are rather evenly split at forty five% 5-stars and 39% 1-star (by having an alert from copyright declaring that the pharmacy may be stacking the deck with "unsupported invitation approaches”), you will see